Moreover, Shim et al. investigated CXCR4 and CXCL12 expression in 283 patients with TNBC by immunohistochemistry, who presented with operable early-stage breast cancer and were treated with surgery and adjuvant chemotherapy [37]. This evidence concerns the gene CXCR4 and breast carcinoma.